An evaluation of the impact of a single-dose intravenous immunoglobulin regimen in the treatment of clostridium difficile infections

M.A. Aldeyab, J.C. McElnay, M.G. Scott, C. Edwards, Elizabeth Davies, F.W. Darwish Elhajji, G. Conlon, F.A. Magee, P.J. Barr, M.P. Kearney

Research output: Contribution to journalLetter

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)631-633
Number of pages3
JournalInfection Control and Hospital Epidemiology
Volume32
Issue number6
DOIs
Publication statusPublished - Jun 2011

Keywords

  • immunoglobulin
  • metronidazole
  • vancomycin
  • aged
  • clinical article
  • Clostridium difficile infection
  • controlled study
  • human
  • length of stay
  • letter
  • male
  • single drug dose
  • treatment outcome
  • Aged, 80 and over
  • Bacterial Toxins
  • Clostridium difficile
  • Clostridium Infections
  • Enterotoxins
  • Female
  • Humans
  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Length of Stay
  • Male
  • Retrospective Studies
  • Treatment Outcome

Cite this

Aldeyab, M. A., McElnay, J. C., Scott, M. G., Edwards, C., Davies, E., Darwish Elhajji, F. W., Conlon, G., Magee, F. A., Barr, P. J., & Kearney, M. P. (2011). An evaluation of the impact of a single-dose intravenous immunoglobulin regimen in the treatment of clostridium difficile infections. Infection Control and Hospital Epidemiology, 32(6), 631-633. https://doi.org/10.1086/660203